NPPA Revises Retail and Ceiling Prices of 35 Drug Formulations; Fixes Prices of 34 New Drugs, Cholecalciferol, Oxaliplatin and Sun Pharma’s Diclofenac Gel
ED attaches assets, freezes bank account in counterfeit medicines racket; searches five premises in Bengaluru
Hyderabad Startup Working On Personalised Cancer Vaccine: What It Means For Cancer Treatment
Medicines that cure Us are making Our Environment Sick
ZEN- G packs a punch in Organ Donation as Over 500 Students pledge Organs
PGIMS recalls drug amid probe into deaths
NPPA list brings little relief: No price cut for 25% cancer drugs
Centre Mandates Minimum One-Year Shelf Life For Imported Drugs
For Aakash Healthcare, Community People are Apples of its Eyes
Not mandatory to recall stocks released to the market prior to implementation of TMR: NPPAPharmacy gets shot in arm
AHMEDABAD: The state being hub of pharmaceutical industry, it does not come as a surprise that the majority of 5,000-odd seats for the Bachelor of Pharmacy (BPharm) were filled for…
Novartis gets European approval for sight therapy Luxturna
ZURICH: Novartis on Friday said it had received European Union approval for its Luxturna gene therapy to restore sight to people with a rare retinal disease. Luxturna is a one-time…
Lupin launches first chatbot for patients to know about their ailments
BENGALURU: Pharma major Lupin launched a chatbot named ‘ANYA’ designed to provide medically verified information for health-related queries. The disease awareness bot aims to answer patient queries related to ailments.…
Dr. Reddy’s shares spike after favourable generic drug ruling
Shares of Indian drugmaker Dr. Reddy’s Laboratories Ltd jumped nearly 9 percent on Wednesday, their sharpest intraday gain in a year, after a U.S. court allowed the company to sell…
Zydus Cadila gets USFDA nod for generic cholesterol drug
New Delhi: Drug maker Zydus Cadila Thursday said it has received approval from the US health regulator to market cholesterol-lowering drug Atorvastatin Calcium tablets. The Ahmedabad-based group has received final…
Glenmark gets USFDA nod for pneumonia treatment drug
New Delhi: Glenmark Pharmaceuticals Thursday said it has received final approval from the US health regulator for Atovaquone, used for prevention and treatment of a type of pneumonia. Glenmark Pharmaceuticals…
Indoco Remedies gets two minor observations from USFDA for Goa plants
New Delhi: Drug firm Indoco Remedies Thursday said it has received two minor observations from the US health regulator for its Goa-based two plants. The US Food and Drug Administration…
Strides board approves USD 15 mn investment in Stelis Biopharma
New Delhi: Strides Pharma Science Thursday said its board has approved plans to invest another USD 15 million in its biotech arm Stelis Biopharma. The company’s board has approved participation…
Monsanto appeals damning Roundup cancer verdict
San Francisco: Monsanto on Tuesday said it is asking an appeals court to toss out a damning verdict in a landmark Roundup weed-killer cancer trial and grant it another try.…
Piramal Enterprises plans to raise up to Rs 1,000 crore via NCDs
NEW DELHI: Piramal Enterprises Wednesday said it plans to raise up to Rs 1,000 crore through issue of secured non-convertible debentures (NCDs) on private placement basis. The administrative committee of…